RedHill Biopharma (RDHL) Inventory Average (2017 - 2025)
RedHill Biopharma (RDHL) posted quarterly Inventory Average of $3.4 million for Q2 2025, down 16.76% year-over-year from $4.1 million in Q2 2024, and down 8.52% quarter-over-quarter from $3.7 million in Q4 2024.
RedHill Biopharma (RDHL) Inventory Average (2017 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Inventory Average for 9 consecutive years, with $3.4 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Inventory Average fell 16.76% year-over-year to $3.4 million; the TTM figure through Jun 2025 stood at $3.4 million (down 16.76% YoY), while the FY2024 annual figure was $4.0 million, down 47.79% from the prior year.
- Inventory Average declined to $3.4 million in Q2 2025 per RDHL's latest filing, from $3.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $14.5 million in Q1 2022 and bottomed at $3.4 million in Q2 2025.
- Historically, Inventory Average has averaged $8.8 million across 5 years, with a median of $8.7 million in 2021.
- Annual changes were most pronounced in 2021 — Inventory Average jumped 239.77% — and 2023, when it tumbled 60.46%.
- RedHill Biopharma's Inventory Average stood at $14.0 million in 2021, then fell by 15.51% to $11.8 million in 2022, then sank by 60.46% to $4.7 million in 2023, then slipped by 20.08% to $3.7 million in 2024, then slipped by 8.52% to $3.4 million in 2025.
- Business Quant data shows RDHL's Inventory Average at $3.4 million in Q2 2025, $3.7 million in Q4 2024, and $4.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.41 Mn |
| Dec 31, 2024 | 3.73 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 8.43 Mn |
| Dec 31, 2022 | 11.80 Mn |
| Sep 30, 2022 | 12.15 Mn |
| Jun 30, 2022 | 13.00 Mn |
| Mar 31, 2022 | 14.54 Mn |
| Dec 31, 2021 | 13.96 Mn |
| Sep 30, 2021 | 10.94 Mn |
| Jun 30, 2021 | 9.02 Mn |
| Mar 31, 2021 | 7.90 Mn |
| Dec 31, 2020 | 5.81 Mn |
| Sep 30, 2020 | 4.93 Mn |
| Jun 30, 2020 | 3.76 Mn |
| Mar 31, 2020 | 2.32 Mn |
| Dec 31, 2019 | 1.92 Mn |
| Sep 30, 2019 | 1.89 Mn |